Myopia: Evidence That Endures

Why robust long-term clinical myopia control evidence is crucial for protecting children’s vision

1

Myopia is a major global health concern, with the WHO projecting 40% of the population will be affected by 2030.
2

Children are particularly vulnerable to myopia, with increased screen time and reduced outdoor activity during the pandemic exacerbating the issue.
3

MiYOSMART spectacle lenses, utilizing DIMS Technology, have shown to slow myopia progression by 59% and reduce axial elongation by 60%.
4

An 8-year study demonstrated sustained myopia control effects in children wearing MiYOSMART lenses, highlighting the importance of long-term use.
5

Long-term evidence is crucial for informed clinical decisions, ensuring children receive effective, evidence-based care for myopia management.

1